Cutler Group LP Seelos Therapeutics, Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.16 - $1.64 $48 - $491	-300 Reduced 48.62%	317 $0
Q1 2023 May 01, 2023	SELL	$0.59 - $1.04 $697 - $1,230	-1,183 Reduced 65.72%	617 $0
Q4 2022 Feb 07, 2023	SELL	$0.66 - $259.46 $1,458 - $573,406	-2,210 Reduced 55.11%	1,800 $1,000
Q3 2022 Oct 25, 2022	BUY	$0.65 - $278.68 $266 - $114,258	410 Added 11.39%	4,010 $4,000
Q2 2022 Aug 04, 2022	SELL	$0.51 - $0.93 $459 - $837	-900 Reduced 20.0%	3,600 $2,000
Q1 2022 Apr 14, 2022	BUY	$0.84 - $1.71 $3,696 - $7,524	4,400 Added 4400.0%	4,500 $3,000
Q2 2021 Jul 19, 2021	SELL	$2.64 - $6.32 $15,576 - $37,288	-5,900 Reduced 98.33%	100 $0
Q1 2021 Apr 26, 2021	BUY	$1.35 - $4.99 $8,100 - $29,940	6,000 New	6,000 $29,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.